For patients grappling with severe major depressive disorder, the drug is appearing as a beacon of hope. Unlike conventional antidepressants, which can take weeks to demonstrate results, the treatment frequently delivers a read more noticeably quick effect. While yet considered an off-label use, substantial data demonstrates its utility in alleviat